COCP (Cocrystal Pharma, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by COCP officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2026-08-06 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2026-08-05 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2026-06-03 | JAMES SAPIRSTEIN | Chief Executive Officer | A | — | — |
| 2026-02-25 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2026-02-09 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2026-01-13 | Fred Hassan | Director | A | — | — |
| 2026-01-13 | Anthony J Japour | Director | A | — | — |
| 2026-01-13 | Steven D Rubin | Director | A | — | — |
| 2026-01-13 | RICHARD C PFENNIGER JR | Director | A | — | — |
| 2026-01-13 | Sam Lee | President and Co-CEO | A | — | — |
| 2026-01-13 | James Joseph Martin | Co-CEO and CFO | A | — | — |
| 2026-01-13 | Roger D. Kornberg | Director | A | — | — |
| 2026-01-13 | PHILLIP MD ET AL FROST | Director | A | — | — |
| 2026-01-02 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2025-12-31 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2025-12-29 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2025-11-28 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2025-11-25 | PHILLIP MD ET AL FROST | Director | Buy | — | — |
| 2025-10-30 | PHILLIP MD ET AL FROST | Director | A | — | — |
| 2025-10-30 | Fred Hassan | Director | A | — | — |
| 2025-10-30 | James Joseph Martin | Co-CEO and CFO | A | — | — |
| 2025-10-30 | RICHARD C PFENNIGER JR | Director | A | — | — |
| 2024-10-11 | Steven D Rubin | Director | A | — | — |
| 2024-10-11 | RICHARD C PFENNIGER JR | Director | A | — | — |
| 2024-10-11 | James Joseph Martin | Co-CEO and CFO | A | — | — |
| 2024-10-11 | PHILLIP MD ET AL FROST | Director | A | — | — |
| 2024-10-11 | Sam Lee | President and Co-CEO | A | — | — |
| 2024-10-11 | Fred Hassan | Director | A | — | — |
| 2024-10-11 | Roger D. Kornberg | Director | A | — | — |
| 2024-10-11 | Anthony J Japour | Director | A | — | — |
| 2023-07-20 | Sam Lee | President and Co-CEO | A | — | — |
| 2023-07-20 | RICHARD C PFENNIGER JR | Director | A | — | — |
| 2023-07-20 | Steven D Rubin | Director | A | — | — |
| 2023-07-20 | Anthony J Japour | Director | A | — | — |
| 2023-07-20 | Roger D. Kornberg | Director | A | — | — |
| 2023-07-20 | James Joseph Martin | Co-CEO and CFO | A | — | — |
| 2023-07-20 | Fred Hassan | Director | A | — | — |
| 2023-07-20 | PHILLIP MD ET AL FROST | Director | A | — | — |
| 2023-04-06 | Frost Gamma Investments Trust | 10%+ Owner | Buy | — | — |
| 2022-08-03 | Sam Lee | President and Co-Interim CEO | A | — | — |
| 2022-08-03 | Steven D Rubin | Director | A | — | — |
| 2022-08-03 | Roger D. Kornberg | Director | A | — | — |
| 2022-08-03 | PHILLIP MD ET AL FROST | Director | A | — | — |
| 2022-08-03 | James Joseph Martin | Co- Interim CEO and CFO | A | — | — |
| 2022-08-03 | Anthony J Japour | Director | A | — | — |
| 2022-08-03 | RICHARD C PFENNIGER JR | Director | A | — | — |
| 2021-08-23 | RICHARD C PFENNIGER JR | Director | Buy | — | — |
| 2021-07-20 | Anthony J Japour | Director | A | — | — |
| 2021-07-20 | Sam Lee | President and Co-Interim CEO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 2,660,242 | — |
| — | Director | 2,020,651 | — |
| — | Director | 1,383,009 | — |
| — | 10%+ Owner | 1,319,838 | — |
| — | Director | 722,546 | — |
| — | President and Co-CEO | 76,355 | — |
| — | Director | 67,878 | — |
| — | Co-CEO and CFO | 44,167 | — |
| — | Director | 31,400 | — |
| — | Director | 14,924 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the COCP quote page; the site-wide leaderboard is on the insider transactions hub.